Ruti Aga: Six Years, and a Prescription Written Inside the Family

A few years ago I went back through the archive footage of the Tokyo Marathon. I had learned to count frames in Kazan, the ones the crowd never sees, and I wanted to know whether that method survived the move from track to road. In the race Ruti Aga won in 2026, her cadence did not drop over the last two kilometres, her stride did not shorten, and her walk-off after the finish line betrayed no surge of fatigue. The footage said one clear thing: she was consistent, coached, built for the podium.

That consistency ended on a piece of paper. The paper was written by a member of her own family who held no medical registration. The clinic whose old prescription pad was supposedly used said flatly that no such pad had ever been issued. One sentence, and the six-year arithmetic was settled.

Writing about a sporting sanction requires deciding what is being measured. No time is being measured here. Three separate things are: a prohibited substance, an explanation, and a false document.

Methylprednisolone is a glucocorticoid, used to reduce inflammation. For a marathon runner with a complaining knee, that prescription is the most ordinary event in medicine. The WADA list prohibits glucocorticoids in competition, by injection, oral or rectal route. Out of competition, under a doctor, it is legitimate treatment, on one condition: it must be documented, and it must be out of the in-competition window.

After she won a half marathon in China in March, her sample returned methylprednisolone. She explained it as treatment for a knee injury. The explanation is credible. The paper submitted with the explanation is not.

That is where the case turns. Doping cases come in two shapes: a substance was found, or a substance was found and someone tried to bury it. The second carries the heavier tariff, because the rule stops asking about philosophy and asks a narrower question: was an investigator misled? Most of the six years answers that second question. There is no prior sanction on record, so the extra years were generated by paperwork, not by blood.

A marathon career is usually read through splits, but the problem here was never in the splits. It was in the medical support structure. The Ethiopian highland pipeline supplies a coach, an agent, a masseur, a physio. What it rarely supplies is a licensed team physician fluent in TUE language, document retention and certificate verification. That is an institutional function, available to a handful of athletes at the very top. Everyone else is treated through a cousin, a friendly doctor, a clinic door that opens quietly and keeps no file.

Her competitive tier matters. A 2026 Tokyo Marathon title plus three World Marathon Major runner-up finishes places her inside the global top fifteen to twenty-five of her generation, and never as the face the event was built around. Income at that tier comes overwhelmingly from appearance fees and podium bonuses rather than global endorsement. A six-year ban is therefore not a marginal loss for her. It is close to total.

The race where the sample was collected was a March half marathon in China, an appearance-fee event far from the elite circuit's cameras, with testing shaped by the local anti-doping body and targeted AIU work. That is the lowest-surveillance zone available to a mid-tier elite. High fee, low oversight: the formula is not new, and it selects precisely for the cases that later collapse into document trouble.

The pharmacologically relevant question is timing, not intent. Glucocorticoids are prohibited only in competition. An injection administered well before the race, properly declared, is a fully legal story. Administered in the days around the race, it is detectable by definition. The framework cannot separate intent from incompetence at that boundary, which is the most uncomfortable part of this case.

The easy reading is that a talented runner has been idled. The harder reading is that the six years were built largely out of documentation failure. Had she submitted no prescription at all and simply given the explanation, the case would likely have sat inside a two-year band, possibly with a no-fault argument attached. The moment a family member signed a dead pad, the matter stopped being a doping case and became a fraud case. The injustice sits right there: the tariff is being set not by the depth of the offence but by the institutional literacy of the accused.

That does not make her innocent. Fabricating a document is a deliberate act. But it does raise the question of why a system has been built in which the most honest route to proving legitimate treatment is also the most dangerous one. Anti-doping is far better at catching paper than at catching pills, because paper can be cross-checked and bodies cannot. The system gravitates toward the evidence it can hold.

She is thirty-two. The sanction runs from 10 September for six years, which means a return at thirty-eight. Marathon peaks arrive late and some athletes race past thirty-five, but six years outside competition and out of the testing pool strips away the training group, the agent network, the racing rhythm. A comeback is not impossible. A return to World Marathon Major podiums effectively is.

The split-time series began as a way to survive blowouts, and it taught me to state the measurement method before any comparison. I have no times here: no winning mark from the Chinese half marathon, no course profile, no confirmation of whether it was a women-only or mixed race, and no way to deduct the first-generation carbon-plate era that her 2026-19 marks already sit inside. So I will not place her marks on any historical list. I will only state the fact that sits outside the race.

The March half marathon title will be annulled, along with the prize money and the ranking points. The 2026 Tokyo title survives this decision untouched. Her name will now carry two records side by side: one intact, one cut.

Back to the frozen contract. The frozen contract was never about money; it was about motion, about who is allowed to move and who is held in place. In Ruti Aga's case, the motion stopped on a prescription pad. The question is no longer whether she was guilty, because that has been settled. The question is how many mid-tier African marathoners will have a prescription written by a cousin in the next five years, because nobody on the team knows what a TUE form looks like. And who, exactly, is going to count them.